CA-01

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCA-01
Drug Alias Nametrispecific antibody-based therapeutic (Biotecnol)CA-01
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotecnol Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A